In a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer has agreed to pay up to $250 million. The settlement, disclosed in a Delaware court filing last week, is intended to significantly reduce Pfizer’s potential liability, reported Financial Times, citing people familiar with the deal.
